Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 3 - Number 1
Partial Dopamine Agonists and the Treatment of Psychosis
, 3(1): 3 - 8Carol A. Tamminga
DOI: 10.2174/1570159052773404
Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
, 3(1): 9 - 34Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn
DOI: 10.2174/1570159052773369
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia
, 3(1): 45 - 62David W. Volk and David A. Lewis
DOI: 10.2174/1570159052773396
Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
, 3(1): 63 - 71Cyrille Sur and Gene G. Kinney
DOI: 10.2174/1570159052773413
Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
, 3(1): 73 - 85W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig and J. Marksteiner
DOI: 10.2174/1570159052773440
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net